NO20013984L - Ny fremgangsmåte for fremstilling av alendronsyre - Google Patents
Ny fremgangsmåte for fremstilling av alendronsyreInfo
- Publication number
- NO20013984L NO20013984L NO20013984A NO20013984A NO20013984L NO 20013984 L NO20013984 L NO 20013984L NO 20013984 A NO20013984 A NO 20013984A NO 20013984 A NO20013984 A NO 20013984A NO 20013984 L NO20013984 L NO 20013984L
- Authority
- NO
- Norway
- Prior art keywords
- alendronic acid
- preparation
- new process
- reacting
- group
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004343 alendronic acid Drugs 0.000 title abstract 3
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 1
- -1 chloro, bromo, iodo, fluoro, hydroxy, amino Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012351 deprotecting agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25163499A | 1999-02-17 | 1999-02-17 | |
| PCT/US2000/003586 WO2000049026A1 (en) | 1999-02-17 | 2000-02-11 | Novel process for preparing alendronic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013984D0 NO20013984D0 (no) | 2001-08-16 |
| NO20013984L true NO20013984L (no) | 2001-10-17 |
Family
ID=22952795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013984A NO20013984L (no) | 1999-02-17 | 2001-08-16 | Ny fremgangsmåte for fremstilling av alendronsyre |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US6201148B1 (is) |
| EP (1) | EP1169326B1 (is) |
| JP (1) | JP3930251B2 (is) |
| KR (1) | KR100665633B1 (is) |
| AT (1) | ATE271057T1 (is) |
| AU (1) | AU770312B2 (is) |
| BG (1) | BG64851B1 (is) |
| BR (1) | BR0010112A (is) |
| CA (1) | CA2363317C (is) |
| CZ (1) | CZ296921B6 (is) |
| DE (1) | DE60012165T2 (is) |
| DK (1) | DK1169326T3 (is) |
| EA (1) | EA003861B1 (is) |
| EE (1) | EE04593B1 (is) |
| ES (1) | ES2222188T3 (is) |
| HK (1) | HK1041004B (is) |
| HR (1) | HRP20010606B1 (is) |
| HU (1) | HUP0200342A3 (is) |
| IL (1) | IL144941A0 (is) |
| IS (1) | IS6050A (is) |
| MX (1) | MXPA01008332A (is) |
| NO (1) | NO20013984L (is) |
| NZ (1) | NZ513551A (is) |
| PL (1) | PL350126A1 (is) |
| PT (1) | PT1169326E (is) |
| SK (1) | SK285163B6 (is) |
| WO (1) | WO2000049026A1 (is) |
| YU (1) | YU59401A (is) |
| ZA (1) | ZA200106816B (is) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60012165T2 (de) * | 1999-02-17 | 2005-08-25 | Teva Pharmaceutical Industries Ltd. | Verfahren zur herstellung von alendron-säure |
| ES2153794B1 (es) * | 1999-08-06 | 2001-10-16 | Medichem Sa | Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada. |
| TR200101250A2 (tr) * | 2001-05-10 | 2003-04-21 | E�S Eczaciba�I �Zg�N K�Myasal �R�Nler Sanay� A.�. | 4-amino-1-hidroksibutiliden-1,1-bifosfonik asit veya tuzlarının hazırlanmasına ilişkin proses |
| US20040052843A1 (en) * | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
| NZ534104A (en) * | 2001-12-24 | 2007-03-30 | Teva Pharma | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material |
| ITMI20020908A1 (it) | 2002-04-29 | 2003-10-29 | Chemi Spa | Processo di preparazione di sodio alendronato |
| HUP0300227A2 (hu) * | 2003-01-28 | 2004-09-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására |
| WO2007083240A2 (en) * | 2006-01-20 | 2007-07-26 | Aurobindo Pharma Limited | An improved process for the preparation of bisphosphonic acids |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US22A (en) * | 1836-09-05 | Spbcificatioh | ||
| US562A (en) * | 1838-01-09 | Scale beam and weight | ||
| DE3016289A1 (de) * | 1980-04-28 | 1981-10-29 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren |
| IT1201087B (it) * | 1982-04-15 | 1989-01-27 | Gentili Ist Spa | Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche |
| US4621107A (en) * | 1982-08-12 | 1986-11-04 | Lagow Richard J | Fluorinated elastomeric materials |
| IT1196315B (it) * | 1984-10-29 | 1988-11-16 | Gentili Ist Spa | Procedimento per la preparazione di acidi difosfonici |
| GB2248063A (en) * | 1990-09-18 | 1992-03-25 | Merck & Co Inc | Phthalimido alkanoyl phosphonates |
| US5039819A (en) * | 1990-09-18 | 1991-08-13 | Merck & Co., Inc. | Diphosphonate intermediate for preparing an antihypercalcemic agent |
| US5159108A (en) * | 1990-09-18 | 1992-10-27 | Merck & Co., Inc. | Process for preparing an antihypercalcemic agent |
| CA2197267C (en) * | 1997-02-11 | 2000-02-08 | Yong Tao | Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
| DE60012165T2 (de) * | 1999-02-17 | 2005-08-25 | Teva Pharmaceutical Industries Ltd. | Verfahren zur herstellung von alendron-säure |
-
2000
- 2000-02-11 DE DE60012165T patent/DE60012165T2/de not_active Expired - Fee Related
- 2000-02-11 SK SK1186-2001A patent/SK285163B6/sk unknown
- 2000-02-11 EP EP00913437A patent/EP1169326B1/en not_active Expired - Lifetime
- 2000-02-11 NZ NZ513551A patent/NZ513551A/xx unknown
- 2000-02-11 CA CA002363317A patent/CA2363317C/en not_active Expired - Fee Related
- 2000-02-11 EA EA200100894A patent/EA003861B1/ru not_active IP Right Cessation
- 2000-02-11 WO PCT/US2000/003586 patent/WO2000049026A1/en active IP Right Grant
- 2000-02-11 PT PT00913437T patent/PT1169326E/pt unknown
- 2000-02-11 IL IL14494100A patent/IL144941A0/xx not_active IP Right Cessation
- 2000-02-11 JP JP2000599764A patent/JP3930251B2/ja not_active Expired - Fee Related
- 2000-02-11 ES ES00913437T patent/ES2222188T3/es not_active Expired - Lifetime
- 2000-02-11 CZ CZ20012942A patent/CZ296921B6/cs not_active IP Right Cessation
- 2000-02-11 BR BR0010112-5A patent/BR0010112A/pt not_active Application Discontinuation
- 2000-02-11 EE EEP200100436A patent/EE04593B1/xx not_active IP Right Cessation
- 2000-02-11 AT AT00913437T patent/ATE271057T1/de not_active IP Right Cessation
- 2000-02-11 HU HU0200342A patent/HUP0200342A3/hu unknown
- 2000-02-11 AU AU34886/00A patent/AU770312B2/en not_active Ceased
- 2000-02-11 DK DK00913437T patent/DK1169326T3/da active
- 2000-02-11 KR KR1020017010358A patent/KR100665633B1/ko not_active IP Right Cessation
- 2000-02-11 PL PL00350126A patent/PL350126A1/xx not_active Application Discontinuation
- 2000-02-11 YU YU59401A patent/YU59401A/sh unknown
- 2000-02-11 MX MXPA01008332A patent/MXPA01008332A/es active IP Right Grant
- 2000-04-21 US US09/556,091 patent/US6201148B1/en not_active Expired - Fee Related
-
2001
- 2001-03-20 US US09/812,469 patent/US20020052527A1/en not_active Abandoned
- 2001-08-16 HR HR20010606A patent/HRP20010606B1/xx not_active IP Right Cessation
- 2001-08-16 NO NO20013984A patent/NO20013984L/no not_active Application Discontinuation
- 2001-08-16 IS IS6050A patent/IS6050A/is unknown
- 2001-08-16 BG BG105825A patent/BG64851B1/bg unknown
- 2001-08-17 ZA ZA200106816A patent/ZA200106816B/xx unknown
-
2002
- 2002-02-27 HK HK02101492.9A patent/HK1041004B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20013984L (no) | Ny fremgangsmåte for fremstilling av alendronsyre | |
| DE69430667D1 (de) | Verfahren zur herstellung von fluoralkenylthio heterozyclische derivate | |
| DE3688587D1 (de) | Verfahren zur herstellung von cefodizim. | |
| ATE384067T1 (de) | Verfahren zur herstellung von 3-cephemderivaten | |
| DE69531219D1 (de) | Verfahren zur umwandlung von 2,4-dichlorpyridinen in 2-aryloxy-4-chlorpyridine | |
| DE69809888D1 (de) | Verfahren zur Herstellung von alpha-Aminoketonen | |
| ATE186737T1 (de) | Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl- lipopeptiden | |
| ATE554094T1 (de) | Verfahren zur herstellung von 3-cephem- verbindungen | |
| DE69839732D1 (de) | Verfahren zur herstellung von 3,4-dihydroxy-3cyclobuten-1,2-dion | |
| DK0614908T3 (da) | Fremgangsmåde til fremstilling af 3beta-aminocholansyrederivater. | |
| DE69821763D1 (de) | Verfahren zur herstellung von 2-alkylthio-substituierten benzoesäurederivaten | |
| DE60142962D1 (de) | Verfahren zur herstellung von pestiziden verbindungen | |
| FI863897A (fi) | Kemiskt foerfarande. | |
| ATE67194T1 (de) | Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung. | |
| ATE209180T1 (de) | Verfahren zur herstellung von malonsäuredinitril | |
| DE3768470D1 (de) | Verfahren zur herstellung von (z)-2-(2-arylethenyl)-arylcarbonsaeuren. | |
| TH37374EX (th) | N-t-บิวทิล-แอนดรอสท-3,5-ไดอีน-17(สูตร)-คาร์บอกซามีด-3-คาร์บอกซิลิค แอซิด พอลิมอร์ฟ | |
| TH37374A (th) | N-t-บิวทิล-แอนดรอสท-3,5-ไดอีน-17(สูตร)-คาร์บอกซามีด-3-คาร์บอกซิลิค แอซิด พอลิมอร์ฟ | |
| DE60306506D1 (de) | Verfahren | |
| ATE226207T1 (de) | Verfahren zur herstellung von beta-lactam verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |